1. Home
  2. RELI vs SPRC Comparison

RELI vs SPRC Comparison

Compare RELI & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Global Group Inc.

RELI

Reliance Global Group Inc.

HOLD

Current Price

$0.63

Market Cap

6.5M

Sector

Finance

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$1.65

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELI
SPRC
Founded
2013
2004
Country
United States
Israel
Employees
64
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
4.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RELI
SPRC
Price
$0.63
$1.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
3.5M
Earning Date
11-06-2025
01-01-0001
Dividend Yield
4.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,115,995.00
$1,306,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
187.98
52 Week Low
$0.61
$1.55
52 Week High
$5.11
$37.59

Technical Indicators

Market Signals
Indicator
RELI
SPRC
Relative Strength Index (RSI) 36.84 33.13
Support Level $0.68 $1.55
Resistance Level $0.83 $2.02
Average True Range (ATR) 0.06 0.32
MACD 0.00 0.03
Stochastic Oscillator 2.57 5.66

Price Performance

Historical Comparison
RELI
SPRC

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: